Ova­Science and Ac­tive Biotech name new CEOs, Valeant adds John Paul­son to the board

→  Ova­Science strug­gled hard last year, drop­ping its CEO, COO and 30% of its staff. Now they have named a new CEO, Christo­pher Kroeger. Kroeger pre­vi­ous­ly spent over a decade at the ven­ture firm The Au­ro­ra Funds, and be­fore that he ran Car­dioxyl, which was sold to Bris­tol-My­ers in 2015 for its heart fail­ure drug. Co-founder and Chair­man Michelle Dipp, who stepped in to helm the com­pa­ny dur­ing its tur­bu­lence, is now tak­ing an ad­vi­so­ry role with the fer­til­i­ty com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER